SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 8,815.96 |
| Enterprise Value ($M) | 3,089.01 |
| Book Value ($M) | 6,584.58 |
| Book Value / Share | 8.17 |
| Price / Book | 1.34 |
| NCAV ($M) | 6,078.64 |
| NCAV / Share | 7.54 |
| Price / NCAV | 1.45 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.63 |
| Return on Assets (ROA) | 1.87 |
| Return on Equity (ROE) | 2.78 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 27.77 |
| Current Ratio | 27.79 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 6,806.73 |
| Assets | 7,312.68 |
| Liabilities | 728.10 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Sumitomo Chemical Co., Ltd. | 0.00 | -100.00 | |
| 13G/A | QVT Financial LP | 8.28 | -40.72 | |
| 13G/A | Dexcel Pharma Technologies Ltd. | 12.78 | 0.00 | |
| 13G/A | Ramaswamy Vivek | 9.75 | 0.00 | |
| 13G/A | Viking Global Investors Lp | 8.60 | -7.80 | |
| 13G/A | Sb Investment Advisers (uk) Ltd | 9.10 | -23.15 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,019,439 | 4,452,792 | 22.89 | |
| 807,585 | 4,606,824 | 17.53 | |
| 718,866 | 1,736,032 | 41.41 | |
| 758,052 | 1,231,930 | 61.53 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RIGL – Rigel Pharmaceuticals, Inc. | RLMD – Relmada Therapeutics, Inc. |
| RLYB – Rallybio Corporation | RPRX – Royalty Pharma plc |
| RPTX – Repare Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io